Keywords: private, labels, erode, 5b, cough, cold, allergy
Private labels erode $4.5B US cough, cold, allergy and sinus market
Article | 04 July 2005
The US market for over-the-counter cough, cold, allergy and sinus medications slid almost 4% in 2004 to just under $4.5 billion, according to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
